Approach to diagnosing celiac disease in patients with low bone mineral density or fragility fractures:Multidisciplinary task force report;Approche au diagnostic de la maladie coeliaque chez les patients ayant une faible densité minérale osseuse ou des fractures de fragilité

Canadian Family Physician

Volumn 59, Issue 10, 2013, Pages

  Rios, Lorena P ^a   Khan, Aliya ^a   Sultan, Muhammad ^b   McAssey, Karen ^a   Fouda, Mona A ^c   Armstrong, David ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; CALCIUM; ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; GLUTEN; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; LEUKOCYTE ANTIGEN; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D;

ADDISON DISEASE; ALKALINE PHOSPHATASE BLOOD LEVEL; ALOPECIA AREATA; AMINOTRANSFERASE BLOOD LEVEL; APHTHOUS ULCER; ATAXIA; AUTOIMMUNE LIVER DISEASE; AUTOIMMUNE THYROIDITIS; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CALCIUM URINE LEVEL; CELIAC DISEASE; CHRONIC DIARRHEA; CLINICAL EVALUATION; COMMON VARIABLE IMMUNODEFICIENCY; COST EFFECTIVENESS ANALYSIS; DERMATITIS HERPETIFORMIS; DOWN SYNDROME; DUODENUM BIOPSY; EMBASE; FALSE POSITIVE RESULT; FAMILY HISTORY; FIRST DEGREE RELATIVE; FRAGILITY FRACTURE; GIARDIA LAMBLIA; GLUTEN FREE DIET; HIGH RISK POPULATION; HISTOLOGY; HLA TYPING; HUMAN; IMMUNOFLUORESCENCE; INFERTILITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BIOPSY; INTESTINE VILLUS ATROPHY; IRON DEFICIENCY ANEMIA; LABORATORY TEST; LOW RISK POPULATION; MEDICAL HISTORY; MEDLINE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; PREDICTIVE VALUE; PREVENTIVE MEDICINE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; REVIEW; SECONDARY HEALTH CARE; SECONDARY HYPERPARATHYROIDISM; SENSITIVITY AND SPECIFICITY; SEROLOGY; SYSTEMATIC REVIEW; TURNER SYNDROME; VITAMIN INTAKE; WEIGHT REDUCTION;

ALGORITHMS; ASYMPTOMATIC DISEASES; BONE DISEASES, METABOLIC; CELIAC DISEASE; DECISION SUPPORT TECHNIQUES; HUMANS; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; RISK ASSESSMENT; RISK FACTORS;

EID: 84886698399     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Green PH, Jabri B. Celiac disease. Annu Rev Med 2006;57: 207-21.
2. Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357(17): 1731-43.
3. Hopper AD, Hadjivassiliou M, Butt S, Sanders DS. Adult coeliac disease. BMJ 2007;335(7619): 558-62.
4. Van Heel DA, West J. Recent advances in coeliac disease. Gut 2006;55(7): 1037-46.
5. Lo W, Sano K, Lebwohl B, Diamond B, Green PH. Changing presentation of adult celiac disease. Dig Dis Sci 2003;48(2): 395-8.
6. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006;131(6): 1981-2002.
7. Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005;128(4 Suppl 1):S57-67.
8. Shahbazkhani B, Malekzadeh R, Sotoudeh M, Moghadam KF, Farhadi M, Ansari R, et al. High prevalence of coeliac disease in apparently healthy Iranian blood donors. Eur J Gastroenterol Hepatol 2003;15(5): 475-8.
9. Tatar G, Elsurer R, Simsek H, Balaban YH, Hascelik G, Ozcebe OI, et al. Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population. Dig Dis Sci 2004;49(9): 1479-84.
10. Sood A, Midha V, Sood N, Malhotra V. Adult celiac disease in northern India. Indian J Gastroenterol 2003;22(4): 124-6.
11. Catassi C, Rätsch IM, Gandolfi L, Pratesi R, Fabiani E, El Asmar R, et al. Why is coeliac disease endemic in the people of the Sahara? Lancet 1999;354(9179): 647-8.
12. Gomez JC, Selvaggio GS, Viola M, Pizarro B, la Motta G, de Barrio S, et al. Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area. Am J Gastroenterol 2001;96(9): 2700-4.
13. Cranney A, Zarkadas M, Graham ID, Butzner JD, Rashid M, Warren R, et al. The Canadian Celiac Health Survey. Dig Dis Sci 2007;52(4):1087-95. Epub 2007 Feb 22.
14. Green PHR, Stavropoulos SN, Panagi SG, Goldstein SL, McMahon DJ, Absan H, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001;96(1): 126-31.
15. Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010;182(17):1864-73. Epub 2010 Oct 12.
16. Catassi C, Rätsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994;343(8891): 200-3.
17. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001;120(3): 636-51.
18. Fiore CE, Pennisi P, Ferro G, Ximenes B, Privitelli L, Mangiafico RA, et al. Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet. Horm Metab Res 2006;38(6): 417-22.
19. Kemppainen T, Kröger H, Janatuinen E, Arnala I, Kosma VM, Pikkarainen P, et al. Osteoporosis in adult patients with celiac disease. Bone 1999;24(3): 249-55.
20. Valdimarsson T, Toss G, Löfman O, Ström M. Three years' follow-up of bone density in adult coeliac disease: significance of secondary hyperparathyroidism. Scand J Gastroenterol 2000;35(3): 274-80.
21. Keaveny AP, Freaney R, McKenna MJ, Masterson J, O'Donoghue DP. Bone remodeling indices and secondary hyperparathyroidism in celiac disease. Am J Gastroenterol 1996;91(6): 1226-31.
22. Fornari MC, Pedreira S, Niveloni S, González D, Diez RA, Vánquez H, et al. Preand post-treatment serum levels of cytokines, IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol 1998;93(3): 413-8.
23. Di Stefano M, Sciarra G, Jorizzo RA, Grillo RL, Cecchetti L, Speziale D, et al. Local and male gonadal factors in the pathogenesis of coeliac bone loss. Ital J Gastroenterol Hepatol 1997;29(Suppl 2):31.
24. Taranta A, Fortunati D, Longo M, Rucci N, lacomino E, Aliberti F, et al. Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. J Bone Miner Res 2004;19(7):1112-21. Epub 2004 Mar 22.
25. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 2001;166(8): 4915-21.
26. Yamada N, Niwa S, Tsujimura T, Iwasaki T, Sugihara A, Futani H, et al. Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity. Bone 2002;30(6): 901-8.
27. Moreno ML, Crusius JB, Cherñavsky A, Sugai E, Sambuelli A, Vazquez H, et al. The IL-1 gene family and bone involvement in celiac disease. Immunogenetics 2005;57(8):618-20. Epub 2005 Sep 29.
28. Taranta A, Fortunati D, Longo M, Rucci N, Iacomino E, Aliberti F, et al. Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. J Bone Miner Res 2004;19(7):1112-21. Epub 2004 Mar 22.
29. Smecuol E, Mauriño E, Vazquez H, Pedreira S, Niveloni S, Mazure R, et al. Gynaecological and obstetric disorders in coeliac disease: frequent clinical onset during pregnancy or the puerperium. Eur J Gastroenterol Hepatol 1996;8(1): 63-89.
30. Ludvigsson JF, Michaelsson K, Ekbom A, Montgomery SM. Coeliac disease and the risk of fractures - a general population-based cohort study. Aliment Pharmacol Ther 2007;25(3): 273-85.
31. West J, Logan RF, Card TR, Smith C, Hubbard R. Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology 2003;125(2): 429-36.
32. Olmos M, Antelo M, Vazquez H, Smecuol E, Mauriño E, Bai JC. Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 2008;40(1):46-53. Epub 2007 Nov 19.
33. Bai JC, Gonzalez D, Mautalen C, Mazure R, Pedreira S, Vazquez H, et al. Longterm effect of gluten restriction on bone mineral density of patients with coeliac disease. Aliment Pharmacol Ther 1997;11(1): 157-64.
34. McFarlane XA, Bhalla AK, Robertson DA. Effect of a gluten free diet on osteopenia in adults with newly diagnosed coeliac disease. Gut 1996;39(2): 180-4.
35. Sategna-Guidetti C, Grosso SB, Grosso S, Mengozzi G, Aimo G, Zaccaria T, et al. The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Aliment Pharmacol Ther 2000;14(1): 35-43.
36. Valdimarsson T, Löfman O, Toss G, Ström M. Reversal of osteopenia with diet in adult coeliac disease. Gut 1996;38(3): 322-7.
37. Moreno ML, Vazquez H, Mazure R, Smecuol E, Niveloni S, Pedreira S, et al. Stratification of bone fracture risk in patients with celiac disease. Clin Gastroenterol Hepatol 2004;2(2): 127-34.
38. Canadian Task Force on the Periodic Health Examination. The periodic health examination [Bibliography]. CMAJ 1979;121(9): 1193-254.
39. Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty C, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005;128(4 Suppl 1):S38-46.
40. Hopper AD, Cross SS, Hurlstone DP, McAlindon ME, Lobo AJ, Hadjivassiliou M, et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 2007;334(7598):729. Epub 2007 Mar 23.
41. Villalta D, Alessio MG, Tampoia M, Tonutti E, Brusca I, Bagnasco M, et al. Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency. Ann N Y Acad Sci 2007;1109: 212-20.
42. Villalta D, Alessio MG, Tampoia M, Tonutti E, Brusca I, Bagnasco M, et al. Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays. Clin Chim Acta 2007;382(1-2):95-9. Epub 2007 Apr 13.
43. James SP. National Institutes of Health Consensus Development Conference Statement on Celiac Disease, June 28-30, 2004. Gastroenterology 2005;128(4 Suppl 1):S1-S9.
44. Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 1999;94(4): 888-94.
45. Buchman AL. Population-based screening for celiac disease: improvement in morbidity and mortality from osteoporosis? Arch Intern Med 2005;165(4): 370-2.
46. Bonamico M, Mariani P, Thanasi E, Ferri M, Nenna R, Tiberti C, et al. Patchy villous atrophy of the duodenum in childhood celiac disease. J Pediatr Gastroenterol Nutr 2004;38(2): 204-7.
47. Ravelli A, Bolognini S, Gambarotti M, Villanacci V. Variability of histologic lesions in relation to biopsy site in gluten-sensitive enteropathy. Am J Gastroenterol 2005;100(1): 177-85.
48. Kaukinen K, Partanen J, Mäki M, Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 2002;97(3): 695-9.
49. Collin P. Should adults be screened for celiac disease? What are the benefits and harms of screening? Gastroenterology 2005;128(4 Suppl 1):S104-8.
50. Mearin ML, Ivarsson A, Dickey W. Coeliac disease: is it time for mass screening? Best Pract Res Clin Gastroenterol 2005;19(3): 441-52.
51. Catassi C, Kryszak D, Louis-Jacques O, Duerksen DR, Hill I, Crowe SE, et al. Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol 2007;102(7):1454-60. Epub 2007 Mar 13.
52. Drummond FJ, Annis P, O'Sullivan K, Wynne F, Daly M, Shanahan F, et al. Screening for asymptomatic celiac disease among patients referred for bone densitometry measurement. Bone 2003;33(6): 970-4.
53. González D, Sugai E, Gomez JC, Oliveri MB, Gomez Acotto C, Vega E, et al. Is it necessary to screen for celiac disease in postmenopausal osteoporotic women? Calcif Tissue Int 2002;71(2):141-4. Epub 2002 Jul 24.
54. Lindh E, Ljunghall S, Larsson K, Lavö B. Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med 1992;231(4): 403-6.
55. Mather KJ, Meddings JB, Beck PL, Scott RB, Hanley DA. Prevalence of IgAantiendomysial antibody in asymptomatic low bone mineral density. Am J Gastroenterol 2001;96(1): 120-5.
56. Nuti R, Martini G, Valenti R, Giovani S, Salvadori S, Avanzati A. Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med 2001;250(4): 361-6.
57. Sanders DS, Patel D, Khan FB, Westbrook RH, Webber CV, Milford-Ward A, et al. Case-finding for adult celiac disease in patients with reduced bone mineral density. Dig Dis Sci 2005;50(3): 587-92.
58. Stenson WF, Newberry R, Lorenz R, Baldus C, Civitelli R. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med 2005;165(4): 393-9.
59. Karakan T, Ozyemisci-Taskiran O, Gunendi Z, Atalay F, Tuncer C. Prevalence of IgA-antiendomysial antibody in a patient cohort with idiopathic low bone mineral density. World J Gastroenterol 2007;13(21): 2978-82.
60. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002;23(3): 327-64.
61. Betterle C, Lazzarotto F, Spadaccino AC, Basso D, Plebani M, Pedini B, et al. Celiac disease in North Italian patients with autoimmune Addison's disease. Eur J Endocrinol 2006;154(2): 275-9.
62. Myhre AG, Aarsetøy H, Undlien DE, Hovdenak N, Aksnes L, Husebye ES. High frequency of coeliac disease among patients with autoimmune adrenocortical failure. Scand J Gastroenterol 2003;38(5): 511-5.
63. Bushara KO. Neurologic presentation of celiac disease. Gastroenterology 2005:128(4 Suppl 1):S92-7.
64. Jokinen J, Peters U, Mäki M, Miettinen A, Collin P. Celiac sprue in patients with chronic oral mucosal symptoms. J Clin Gastroenterol 1998:26(1): 23-6.
65. Corazza GR, Andreani ML, Venturo N, Bernardi M, Tosti A, Gasbarrini G. Celiac disease and alopecia areata: report of a new association. Gastroenterology 1995;109(4): 1333-7.
66. Fessatou S, Kostaki M, Karpathios T. Coeliac disease and alopecia areata in childhood. J Paediatr Child Health 2003;39(2): 152-4.
67. Rostami K, Kerckhaert J, Tiemessen R, Meijer JW, Mulder CJ. The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrate. Eur J Gastroenterol Hepatol 1999;11(4): 439-42.
68. Tursi A, Brandimarte G, Giorgetti GM. Sorbitol H2-breath test versus anti-endomysium antibodies for the diagnosis of subclinical/silent coeliac disease. Scand J Gastroenterol 2001;36(11): 1170-2.
69. Tursi A, Brandimarte G, Giorgetti GM. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 2003;36(3): 219-21.
70. AGA Institute. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology 2006;131(6): 1977-80.
71. Hill PG, Forsyth JM, Semeraro D, Holmes GK. IgA antibodies to human tissue transglutaminase: audit of routine practice confirms high diagnostic accuracy. Scand J Gastroenterol 2004;39(11): 1078-82.
72. Armstrong D, Don-Wauchope AC, Verdu EF. Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity. Can J Gastroenterol 2011;25(4): 193-7.
73. Dickey W, Kearney N. Overweight in celiac disease: prevalence, clinical characteristics, and effects of a gluten-free diet. Am J Gastroenterol 2006;101(10): 2356-9.